Turnstone Biologics Corp. Common Stock (TSBX) — Financial Flexibility Index
Turnstone Biologics Corp. Common Stock (TSBX) has a Financial Flexibility Index of -0.68x as of June 2025. Free cash flow of $-4.30 Million (operating CF $-4.30 Million minus capex $0.00) represents -1% of total liabilities ($6.34 Million). Check Turnstone Biologics Corp. Common Stock asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Turnstone Biologics Corp. Common Stock Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Turnstone Biologics Corp. Common Stock across 4 annual periods. See Turnstone Biologics Corp. Common Stock working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Turnstone Biologics Corp. Common Stock (2021–2024)
Year-by-year free cash flow to debt coverage for Turnstone Biologics Corp. Common Stock. For the full company profile including market capitalisation, see TSBX stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -7.75x | $-67.21 Million | $-67.44 Million | $8.67 Million | ▼ -68.9% |
| 2023 | -4.59x | $-64.90 Million | $-66.15 Million | $14.15 Million | ▼ -1406.6% |
| 2022 | -0.30x | $-65.89 Million | $-71.06 Million | $216.41 Million | ▼ -94.1% |
| 2021 | -0.16x | $-42.22 Million | $-45.63 Million | $269.10 Million | — |